Intuitive Surgical, Inc. $ISRG Stock Position Lifted by AustralianSuper Pty Ltd

AustralianSuper Pty Ltd lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 763.6% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 105,021 shares of the medical equipment provider’s stock after purchasing an additional 92,860 shares during the quarter. AustralianSuper Pty Ltd’s holdings in Intuitive Surgical were worth $57,069,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Chilton Capital Management LLC lifted its holdings in shares of Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 43 shares during the period. Elite Financial Inc. acquired a new stake in shares of Intuitive Surgical in the first quarter valued at $26,000. Princeton Global Asset Management LLC acquired a new stake in shares of Intuitive Surgical in the second quarter valued at $30,000. LFA Lugano Financial Advisors SA acquired a new stake in shares of Intuitive Surgical in the first quarter valued at $30,000. Finally, TD Capital Management LLC lifted its holdings in shares of Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 45 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on ISRG. The Goldman Sachs Group cut their price objective on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating for the company in a report on Wednesday, October 1st. Truist Financial set a $620.00 price objective on Intuitive Surgical and gave the company a “buy” rating in a report on Wednesday. BTIG Research upped their price objective on Intuitive Surgical from $529.00 to $589.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Intuitive Surgical in a report on Wednesday, October 8th. Finally, Royal Bank Of Canada set a $625.00 target price on Intuitive Surgical and gave the company an “outperform” rating in a report on Wednesday. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $602.32.

Intuitive Surgical Stock Down 0.9%

Shares of NASDAQ ISRG opened at $546.51 on Monday. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The company has a market cap of $195.91 billion, a price-to-earnings ratio of 72.29, a P/E/G ratio of 5.02 and a beta of 1.61. The business has a fifty day simple moving average of $458.09 and a 200-day simple moving average of $497.11.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating the consensus estimate of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.Intuitive Surgical’s revenue was up 22.9% compared to the same quarter last year. During the same period in the prior year, the business posted $1.84 earnings per share. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity

In related news, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the sale, the insider directly owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Amy L. Ladd sold 335 shares of the stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the sale, the director directly owned 739 shares of the company’s stock, valued at approximately $325,669.91. This represents a 31.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 30,031 shares of company stock valued at $14,177,895. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.